In consistent with their facilitatory role in lipid degradation [14], circRNA_0046367-induced normalization of both CPT2 and ACBD3 resultantly attenuated the hepatic steatosis by statistical downregulation of TG content. The gene discussed is CPT2; the disease is fatty liver disease.